)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Corline Biomedical
Corline Biomedical (CLBIO) investor relations material
Corline Biomedical Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary8 May, 2026
Executive summary
Achieved record quarterly revenue from commercial product and reagent sales in Q1 2026, with nearly 90% of revenue from these sources.
Strategic focus on expanding partnerships, especially with Kardium, and strengthening presence in the US market.
Ongoing efforts to secure partnerships for Renaparin® and further develop the CHSTM Growth Initiative.
Financial highlights
Net sales reached 4,291 KSEK, up from 2,055 KSEK year-over-year and higher than Q4 2025.
Result after financial items improved to -2,501 KSEK from -3,071 KSEK year-over-year.
Earnings per share were -0.10 SEK, compared to -0.13 SEK in Q1 2025.
Cash and cash equivalents at period end were 32,902 KSEK, up from 11,735 KSEK year-over-year.
Equity at period end was 102,948 KSEK, with an equity ratio of 86.9%.
Outlook and guidance
Expectation that product and reagent sales will continue to dominate revenue mix, improving margins.
Anticipate further growth driven by expanded US market presence and strengthened partnerships.
Impact of product mix shift on profit margins
Strategic value of Kardium board seat and funding
Rationale for US agent model and catheter focus
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Corline Biomedical
- First US commercial use of CHS™ and strong financing set stage for 2026 growth.CLBIO
Q4 202517 Feb 2026 - Breakthrough quarter with FDA approval, long-term deal, and capital raise set stage for growth.CLBIOQ3 202518 Nov 2025
- Growth depends on Kardium's US launch, with cost cuts improving results despite lower sales.CLBIOQ2 202526 Aug 2025
- Sharply reduced costs and strategic focus position Corline for growth and profitability by 2025.CLBIOQ3 202413 Jun 2025
- Revenue down, losses widened, but US launch and new projects drive future potential.CLBIOQ2 202413 Jun 2025
- Corline's Q1 2025 loss widens, but US market entry and strong clinical data drive optimism.CLBIOQ1 20256 Jun 2025
- 2024 saw heavy losses and restructuring, but Corline targets US growth with CHSTM-coated Globe®.CLBIOQ4 20245 Jun 2025
Next Corline Biomedical earnings date
Q2 202626 Aug, 2026
Corline Biomedical
Next Corline Biomedical earnings date
Q2 202626 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage